DSM Shares Surge to Record on Improved Earnings Forecast

Updated on
  • Vitamin maker benefits from cost saving to boost margins: CEO
  • Nutrition Ebitda advances 14%; materials increases by 10%

DSM CEO Says He's on Track With All His Programs

Royal DSM NV shares rose to a record after the world’s largest vitamin maker raised its outlook on higher demand for animal supplements and materials such as resins while reaping the benefits of cost savings.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.